Outlook Therapeutics, Inc.

NasdaqCM:OTLK Stock Report

Market Cap: US$200.4m

Outlook Therapeutics Balance Sheet Health

Financial Health criteria checks 2/6

Outlook Therapeutics has a total shareholder equity of $-24.3M and total debt of $36.5M, which brings its debt-to-equity ratio to -150.1%. Its total assets and total liabilities are $21.7M and $46.0M respectively.

Key information

-150.1%

Debt to equity ratio

US$36.54m

Debt

Interest coverage ration/a
CashUS$10.36m
Equity-US$24.34m
Total liabilitiesUS$46.03m
Total assetsUS$21.68m

Recent financial health updates

Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt In A Risky Way?

Nov 03
Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt In A Risky Way?

Is Outlook Therapeutics (NASDAQ:OTLK) Using Too Much Debt?

Jul 06
Is Outlook Therapeutics (NASDAQ:OTLK) Using Too Much Debt?

Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt Sensibly?

Apr 01
Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt Sensibly?

Outlook Therapeutics (NASDAQ:OTLK) Has Debt But No Earnings; Should You Worry?

Jun 24
Outlook Therapeutics (NASDAQ:OTLK) Has Debt But No Earnings; Should You Worry?

Recent updates

Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt In A Risky Way?

Nov 03
Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt In A Risky Way?

Outlook Therapeutics resubmits application for eye disease wAMD drug, shares rise 8%

Aug 30

Outlook Therapeutics GAAP EPS of -$0.08 misses by $0.01

Aug 10

Is Outlook Therapeutics (NASDAQ:OTLK) Using Too Much Debt?

Jul 06
Is Outlook Therapeutics (NASDAQ:OTLK) Using Too Much Debt?

Outlook Therapeutics announces full cash pre-payment of convertible promissory note

Jul 05

Outlook Therapeutics: A One-Buck Lottery Ticket

Jun 09

Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt Sensibly?

Apr 01
Is Outlook Therapeutics (NASDAQ:OTLK) Using Debt Sensibly?

Outlook Therapeutics: Likely FDA Approval, Possible Buyout

Jan 21

Outlook Therapeutics (NASDAQ:OTLK) Has Debt But No Earnings; Should You Worry?

Jun 24
Outlook Therapeutics (NASDAQ:OTLK) Has Debt But No Earnings; Should You Worry?

Outlook Therapeutics completes patient dosing in wet AMD trial

Jun 08

Financial Position Analysis

Short Term Liabilities: OTLK has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: OTLK has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: OTLK has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: OTLK's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OTLK has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: OTLK is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.